SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sunil Healthcare - Quaterly Results

11 Aug 2023 Evaluate
The sales moved down -35.06% to Rs. 221.32 millions for the June 2023 quarter as compared to Rs. 340.81 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -7.56 millions as compared to Net Profit of Rs. 44.67 millions of corresponding quarter ended June 2022Operating profit for the quarter ended June 2023 decreased to 18.88 millions as compared to 85.48 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 221.32 340.81 -35.06 221.32 340.81 -35.06 1118.30 1163.73 -3.90
Other Income 8.16 3.35 143.58 8.16 3.35 143.58 16.29 15.54 4.83
PBIDT 18.88 85.48 -77.91 18.88 85.48 -77.91 209.37 193.66 8.11
Interest 12.66 8.19 54.58 12.66 8.19 54.58 41.68 34.89 19.46
PBDT 6.22 77.29 -91.95 6.22 77.29 -91.95 167.69 158.77 5.62
Depreciation 16.08 16.30 -1.35 16.08 16.30 -1.35 70.10 63.06 11.16
PBT -9.86 60.99 -116.17 -9.86 60.99 -116.17 97.59 95.71 1.96
TAX -2.30 16.32 -114.09 -2.30 16.32 -114.09 27.82 27.95 -0.47
Deferred Tax -2.30 6.14 -137.46 -2.30 6.14 -137.46 11.07 12.80 -13.52
PAT -7.56 44.67 -116.92 -7.56 44.67 -116.92 69.77 67.76 2.97
Equity 102.55 102.55 0.00 102.55 102.55 0.00 102.55 102.55 0.00
PBIDTM(%) 8.53 25.08 -65.99 8.53 25.08 -65.99 18.72 16.64 12.50

Sunil Healthcare Share Price

64.00 -1.40 (-2.14%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3628.65
Tata Chemicals 801.15
SRF 2527.60
Pidilite Inds. 1363.45
Deepak Nitrite 1771.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×